Who are andrographolide sulfonate simulation's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Liposomal curcumin, Micro-particle Curcumin.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/andrographolide-sulfonate-simulation.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

andrographolide sulfonate simulation — Competitive Intelligence Brief

andrographolide sulfonate simulation (andrographolide sulfonate simulation) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Natural product derivative; anti-inflammatory agent. Area: Immunology; Infectious Disease.

marketed Natural product derivative; anti-inflammatory agent Immunology; Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

andrographolide sulfonate simulation (andrographolide sulfonate simulation) — Jiangxi Qingfeng Pharmaceutical Co. Ltd.. Andrographolide sulfonate is a water-soluble derivative of andrographolide that exerts anti-inflammatory and immunomodulatory effects through multiple cellular pathways.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
andrographolide sulfonate simulation TARGET	andrographolide sulfonate simulation	Jiangxi Qingfeng Pharmaceutical Co. Ltd.	marketed	Natural product derivative; anti-inflammatory agent
Liposomal curcumin	Liposomal curcumin	University of Florida	marketed	Natural product derivative; anti-inflammatory/antioxidant agent
Micro-particle Curcumin	Micro-particle Curcumin	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	phase 3	Natural product derivative / Anti-inflammatory agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Natural product derivative; anti-inflammatory agent class)

Jiangxi Qingfeng Pharmaceutical Co. Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). andrographolide sulfonate simulation — Competitive Intelligence Brief. https://druglandscape.com/ci/andrographolide-sulfonate-simulation. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab